Peripartum Cardiomyopathy: Case Report dan Literature Review

Peripartum Cardiomyopathy (PPCM) is a form of heart failure that appears at the end of pregnancy or within a few months after delivery, with an etiology that is not fully understood. The incidence of PPCM varies globally, with a higher prevalence in developing countries than in developed countries. This disease has a significant mortality rate if it is not diagnosed and treated properly. This research aims to analyze cases of PPCM in postpartum patients one week after delivery with the main complaint of worsening shortness of breath. The research method used was a clinical case research with a descriptive approach. Data was obtained through anamnesis, physical examination, supporting examinations such as electrocardiography (ECG), echocardiography, chest x-rays, and analysis of Brain Natriuretic Peptide (BNP) and prolactin levels. The results of the research were compared with the latest literature on the diagnosis, management, and prognosis of PPCM. The results showed that the patient's cardiac ejection fraction decreased to 15%, improving to 40% after four months of intensive therapy. A combination of therapies including diuretics, ACE inhibitors, beta blockers, and bromocriptine was shown to contribute to the improvement of the patient's heart function. The implications of this research highlight the importance of early detection and optimal management of PPCM to reduce mortality and morbidity rates. Comprehensive clinical evaluation and appropriate treatment can improve patient recovery.